All In Biotech

Free tool

FAERS Monitor: Keveyis

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 011366 or its brand name (Keveyis, Dichlorphenamide). Reports on generic versions are filed under their own applications.

Reports

1,646

Serious

461

28% of reports

Hospitalization

253

Death reported

13

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • paraesthesia304
  • fatigue231
  • disease recurrence173
  • muscular weakness165
  • feeling abnormal162
  • wrong technique in product usage process151
  • asthenia145
  • confusional state129
  • dizziness119
  • nausea117
  • headache102
  • blood potassium decreased97
  • dysgeusia93
  • malaise92
  • condition aggravated91

Reports by year received

View as table
YearReports
20091
20159
201637
2017158
2018313
2019261
2020295
2021348
202233
202338
202463
202555
202635

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,513 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
disease recurrenceSignal17346.640.57,669
blood potassium decreasedSignal9741.434.13,773
paraesthesiaSignal30424.722.36,939
muscular weaknessSignal16518.616.12,737
dysgeusiaSignal9316.013.11,297
confusional stateSignal12910.28.61,070
wrong technique in product usage processSignal1519.58.21,154
feeling abnormalSignal1628.67.51,099
astheniaSignal1454.94.2458
condition aggravatedSignal913.83.1190
fatigueSignal2313.83.4490
dizzinessSignal1193.02.6166
malaiseSignal922.72.297
headacheSignal1022.11.758
nausea1171.91.650

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.